| Serial Number | 79320342 |
| Word Mark | LBIOME |
| Filing Date | Thursday, May 20, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 25, 2023 |
| Registration Number | 7033011 |
| Registration Date | Tuesday, April 25, 2023 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, February 7, 2023 |
| Goods and Services | Customized manufacture, for third parties, of pharmaceuticals, nutritional and food supplements featuring live or inactivated microorganisms; manufacture of ingredients comprising inactivated, heat-treated Lactobacillus strains and their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; custom manufacture, for third parties, of pharmaceutical and nutritional supplemental ingredients, namely, enriched culture medium and heat-treated microorganisms; manufacture of pharmaceutical ingredients, namely, heat-treated micro-organisms, for preparation of tablets, capsules, powders, injectable products, suspensions, liquids, for medical and veterinary use |
| Description of Mark | The mark consists of the stylized wording "LBIOME" and design featuring the letters LB semi-connected and the letter O featured as a circle with ten small ovals, on a tilt, inside the circle. |
| Goods and Services | Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, autisms, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, obsessive-compulsive disorders, addiction, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, necrotizing enterocolitis, enteritis, skin inflammation, and skin infections, and veterinary pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, enteritis, skin inflammation, and skin infections; dietetic foods adapted for medical and veterinary use; bacterial preparations for medical and veterinary use; probiotic bacteria preparations for medical use; foodstuffs and nutritional and food supplements featuring live or inactivated microorganisms, namely, nutritional supplements, enzyme food supplements, dietary food supplements, food supplements for humans and animals; ingredients based on inactive bacteria preparations and heattreated and heat-stabilized bacteria preparations, namely, Lactobacillus strains in combination with fermentation medium featured as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; ingredients based on combinations of inactivated and heat-treated Lactobacillus delbrueckii and Lactobacillus fermentum and fermentation medium sold as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; additives in the nature of dietary supplements for humans or for animals; ferments for medical or veterinary use with postbiotic or probiotic effects |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical and pharmaceutical research and development in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; scientific research and development; bacteriological scientific research and consultation; provision of information and data relating to medical and veterinary research and development; provision of scientific and technological information in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; design and development of pharmaceuticals, nutritional supplements and dietetic supplements comprising living and inactivated microorganisms; research and development of formulations, namely, pharmaceuticals, nutritional supplements, and dietary supplements for the administration of heat-treated Lactobacillus strains combined with their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; research and development of pharmaceutical ingredients based on enriched culture medium and heat-treated bacteria, namely, Lactobacillus strains; research and development of formulations, namely, pharmaceutials, nutritional supplements, and dietetic supplements, based on enriched culture medium and heat-treated micro-organisms; technological consultation in the field of bacteria-based ingredients and in the field of postbiotics |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 24, 2021 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 24, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 24, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | DSM - Firmenich Houdan SAS |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 98 - Unknown |
| Address | FR |
| Party Name | Adare Pharmaceuticals SAS |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Party Name | Adare Pharmaceuticals SAS |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Party Name | Adare Pharmaceuticals SAS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Event Date | Event Description |
| Thursday, September 16, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, September 24, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 28, 2021 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, February 1, 2022 | ASSIGNED TO EXAMINER |
| Thursday, February 10, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, February 11, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, March 9, 2022 | REFUSAL PROCESSED BY MPU |
| Wednesday, March 9, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sunday, March 27, 2022 | REFUSAL PROCESSED BY IB |
| Tuesday, July 26, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, July 26, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, July 26, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, July 26, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 26, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, August 5, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 5, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 5, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, September 3, 2022 | FINAL REFUSAL WRITTEN |
| Saturday, September 3, 2022 | FINAL REFUSAL E-MAILED |
| Saturday, September 3, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, December 30, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, December 30, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, December 31, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 4, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 17, 2023 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Wednesday, January 18, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, January 18, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, January 18, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, January 30, 2023 | ASSIGNED TO PETITION STAFF |
| Wednesday, February 1, 2023 | POST PUBLICATION AMENDMENT RECEIVED |
| Wednesday, February 1, 2023 | ASSIGNED TO PETITION STAFF |
| Tuesday, February 7, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 7, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 7, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, February 7, 2023 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Wednesday, February 22, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, February 22, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, March 14, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, April 25, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 25, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, August 2, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, August 2, 2023 | FINAL DISPOSITION PROCESSED |
| Tuesday, July 25, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, October 6, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, July 19, 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Saturday, November 4, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Sunday, August 20, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, October 6, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, October 6, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |